FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:659-660 August 31, 2000 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Tefferi, A. PubMed Citation

To the Editor: We would like to report additional data concerning the results of allogeneic stem-cell transplantation for myelofibrosis with myeloid metaplasia, which were recently summarized by Tefferi (April 27 issue).¹ Since our initial report,² we have collected data on 11 new patients and have obtained further follow-up information on the original 55 patients. In an analysis of the overall group of 66 patients, the neutrophil-recovery rate remains high, rising to 84 percent by day 30. In a multivariate analysis, factors that remain associated with delayed engraftment are a low dose of nucleated cells, the absence of a pretransplantation splenectomy, . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Rondelli, D. (2008). Allogeneic hematopoietic stem cell transplantation for myelofibrosis. haematol 93: 1449-1450 [Full Text]  
• Patriarca, F., Bacigalupo, A., Sperotto, A., Isola, M., Soldano, F., Bruno, B., van Lint, M. T., Iori, A. P., Santarone, S., Porretto, F., Pioltelli, P., Visani, G., Iacopino, P., Fanin, R., Bosi, A., on behalf of the GITMO, (2008). Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). haematol 93: 1514-1522 [Abstract] [Full Text]  
• Hoffman, R., Rondelli, D. (2007). Biology and Treatment of Primary Myelofibrosis. ASH Education Book 2007: 346-354 [Abstract] [Full Text]  
• Arana-Yi, C., Quintas-Cardama, A., Giles, F., Thomas, D., Carrasco-Yalan, A., Cortes, J., Kantarjian, H., Verstovsek, S. (2006). Advances in the Therapy of Chronic Idiopathic Myelofibrosis. The Oncologist 11: 929-943 [Abstract] [Full Text]  
• Rondelli, D., Barosi, G., Bacigalupo, A., Prchal, J. T., Popat, U., Alessandrino, E. P., Spivak, J. L., Smith, B. D., Klingemann, H. G., Fruchtman, S., Hoffman, R. (2005). Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia. Blood 105: 4115-4119 [Abstract] [Full Text]  
• O'Brien, S., Tefferi, A., Valent, P. (2004). Chronic Myelogenous Leukemia and Myeloproliferative Disease. ASH Education Book 2004: 146-162 [Abstract] [Full Text]  
• Tefferi, A. (2003). The Forgotten Myeloproliferative Disorder: Myeloid Metaplasia. The Oncologist 8: 225-231 [Abstract] [Full Text]  
• Devine, S. M., Hoffman, R., Verma, A., Shah, R., Bradlow, B. A., Stock, W., Maynard, V., Jessop, E., Peace, D., Huml, M., Thomason, D., Chen, Y.-H., van Besien, K. (2002). Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia. Blood 99: 2255-2258 [Abstract] [Full Text]  
• Deeg, H. J., Appelbaum, F. R. (2001). Stem-Cell Transplantation for Myelofibrosis. NEJM 344: 775-776 [Full Text]